This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Angiogenesis Assays Market

Market Insights on Angiogenesis Assays covering sales outlook, demand forecast & up-to-date key trends

Angiogenesis Assay Market By Product Type (Angiogenesis Tube Formation Assays, Microfluidic Angiogenesis Assays, Invasion and Migration Assays), Application (In Vitro Angiogenesis, In Vivo Angiogenesis), End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) & Region - Forecast 2022-2032

Angiogenesis Assays Market Overview

Global Angiogenesis Assay Market demand is anticipated to be valued at US$ 1.97 Billion in 2022, forecast to grow at a CAGR of 9% to be valued at US$ 4.65 Billion from 2022 to 2032. The growth of the Angiogenesis Assay Market is attributed to its global utilization across the Healthcare industry.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 1.81 Billion

Expected Market Value (2022)

US$ 1.97 Billion

Anticipated Forecast Value (2032)

US$ 4.65 Billion

Projected Growth Rate (2022-2032)

9% CAGR

Angiogenesis is the process of formation of new blood vessels from pre-existing vasculature. It involves the proliferation, migration, and differentiation of endothelial cells which leads to increased vascularization. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer.

Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

North America is considered to be a dominant region for the Angiogenesis Assay Market, owing to the increase in diseases such as tumor formulations, diabetic retinopathy, obesity and metastasis.

The major factor that is expected to augment the growth of the Angiogenesis Assay Market during the forecast period includes the increasing number of research and development activities in this field

The factor that is expected to hinder the growth of the Angiogenesis Assay Market during the forecast period includes lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays

Which are Some Prominent Drivers Spearheading Angiogenesis Assay Market Growth?

The major factor that is expected to drive the growth of Angiogenesis Assay Market during the forecast period includes an increasing number of research and development activities in this field. Moreover, rising R&D spending on cancer therapeutics is another major factor that is expected to fuel the market growth.

In addition, some other factors that are anticipated to accelerate the growth of the Angiogenesis Assay Market during the forecast period include an increasing medical tourism in some regions. Further, factors such as availability of government initiatives supporting research activities and product development are also favoring the market growth.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Angiogenesis Assay Industry?

The major factor that is expected to hamper the growth of the Angiogenesis Assay Market during the forecast period includes scaling up this technique, which tends to make biochemical analysis of the molecular events mediating wound repair difficult. 

The other challenge that hinders the market growth includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays currently in use.

How is North America Emerging as an Opportunistic Angiogenesis Assay Market?

North America holds the major share of the market, attributed to the developed infrastructure, high spending capacity as well as strict regulations in the Angiogenesis Assay Market

In addition, the other factor that is expected to accelerate the market growth in the region includes the increase in diseases such as tumor formulations, diabetic retinopathy, obesity and metastasis. Additionally, North America Angiogenesis Assay Market is expected to expand at a 8% CAGR during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Asia Pacific Contributing to Growth of the Angiogenesis Assay Market?

According to Future Market Insights, Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the increased investments from the manufacturers.

Further, the Asia Pacific countries including India and China are anticipated to favor the growth of the Angiogenesis Assay Market during the forecast period, attributed to rising prevalence of the chronic diseases, and increasing cell-based studies in the region.

Market Competition

Some of the key participants present in the global angiogenesis assay market include Cell Biolabs, Inc., Thermo Fisher Scientific, Abcam Plc., PromoCell GmbH, and Merck KGaA, among others.

Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Cell Biolabs, Inc., and Thermo Fisher Scientific account for a considerable market size, several regional level players are also operating across key growth regions, particularly in the North America.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope of Report

Report Attribute

Details

Growth Rate

CAGR of 9% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Application
  • End Users
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • China
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Cell Biolabs, Inc.
  • Thermo Fisher Scientific
  • Abcam plc.
  • PromoCell GmbH
  • Merck KGaA

Customization

Available Upon Request

Key Segments Profiled in the Angiogenesis Assay Industry Survey

Product Type:

  • Angiogenesis Tube Formation Assays
  • Microfluidic Angiogenesis Assays
  • Endothelial Adhesion
  • Invasion and Migration Assays

Application:

  • In Vitro Angiogenesis
  • In Vivo Angiogenesis

End User:

  • Angiogenesis Assays for Hospitals
  • Angiogenesis Assays for Specialty Clinics
  • Angiogenesis Assays for Ambulatory Surgical Centers

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • China
  • Japan
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global Angiogenesis Assay Market to expand at a 9% value CAGR by 2032

North America is expected to be the most opportunistic Angiogenesis Assay Market, expanding at a 8% CAGR

Cell Biolabs, Inc., Thermo Fisher Scientific, Abcam Plc., PromoCell GmbH, and Merck KGaA, among others are some prominent Angiogenesis Assay Market players

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Lateral Flow Assays Market

Published : February 2022

Healthcare

Diabetic Assays Market

Published : January 2020

Healthcare

Cytotoxicity Assays Market

Published : July 2019

Healthcare

Custom Assays Market

Published : March 2017

Google translate

Angiogenesis Assays Market